Clinical Research

Share:

Here at PENS we are very interested in continuing to provide the most advanced and comprehensive care for children with special needs.  Our research department has conducted more than 50 clinical trials, most of which have provided essential information leading to the FDA approval of the most recent treatments for conditions such as treatment resistant epilepsy, headache, ADHD, and Tourette's Syndrome in children and adolescents.

We have ongoing studies in these areas, including CBD and other new treatments, which are only available under protocols that are approved by the FDA and Institutional Review Boards. If your child has any of these conditions and continues to be inadequately controlled, we are available to provide evaluation for possible participation in a controlled clinical trial.

Below you will find a list of the current research studies we are conducting, as well as links to specific information about the studies. For additional information, please contact the research department at (813) 873-7367 Ext. 210.

  • Primary Generalized Tonic-Clonic Seizures (4 years and older)
  • Partial Onset Seizures or Generalized Epilepsy (6 - 65 years)
  • Any Seizure Type (1 month - less than 24 months)
  • Childhood Absence Epilepsy (3 - 17 years)
  • Dravet Syndrome
  • Lennox-Gastaut Syndrome

To learn more about research studies or to find trials on a specific medical condition, please visit www.clinicaltrials.gov.

Jose Ferreira, MD - Principal Investigator
Mayra Ferreira, CCRC - Research Coordinator